Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

A protein that stops cells from dividing in response to damage or stress could be a new biomarker or therapeutic target for ...

Scientists have developed a powerful new injectable treatment that, when administered after a heart attack, helps the heart ...

A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...

FDA clears Nurix Therapeutics, Inc.'s GS-6791 for inflammatory disorders; Nurix earns $5M milestone from Gilead. Click for my ...

Two PROTAC synergy using two E3 ligases for achieving levels of degradation of KRAS G12D not achieved with single PROTACs, ...

According to data compiled by S&P Global Market Intelligence, Kymera Therapeutics (NASDAQ: KYMR) notched an almost 23% share ...

DiaMedica Therapeutics Inc.’s DMAC share price has dipped by 7.41%, which has investors questioning if this is right time to ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

Evotec announces progress in strategic protein degradation research collaboration with Bristol Myers Squibb: Hamburg, Northern Germany Saturday, April 26, 2025, 13:00 Hrs [IST] Ev ...

Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure.